The invention provides a composition containing hyaluronic acid (HA) or a pharmaceutically-acceptablesalt thereof preserved with a cationic preservative and related methods. Inone embodiment, the pharmaceutically-acceptable salt is sodium hyaluronate.In another embodiment, the cationic preservative includes benzalkonium chloride(BAK).